PTIX - Protagenic Therapeutics, Inc.\new
3.04
-0.240 -7.895%
Share volume: 110,226
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$3.28
-0.24
-0.07%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-15-2024 | 08-14-2023 | 11-14-2023 | 11-14-2024 | 05-15-2024 | 08-14-2024 | 11-14-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 739.294 K | 1.144 M | 1.432 M | 1.212 M | 1.738 M | 1.667 M | 652.066 K | |
| Selling general and admin | 391.263 K | 307.363 K | 307.682 K | 200.799 K | 277.613 K | 453.298 K | 287.882 K | |
| Research and development | 348.031 K | 836.379 K | 1.124 M | 1.011 M | 1.461 M | 1.214 M | 364.184 K | |
| Total expenses | 739.294 K | 1.144 M | 1.432 M | 1.212 M | 1.738 M | 1.667 M | 652.066 K | |
| 54.71% | 25.18% | -15.33% | 43.40% | -4.09% | -60.89% | |||
| Operating income | -739.294 K | -1.144 M | -1.432 M | -1.212 M | -1.738 M | -1.667 M | -652.066 K | |
| Ebit | -739.294 K | -1.263 M | -1.434 M | -1.212 M | -1.738 M | -1.616 M | -652.066 K | |
| Pretax income | -718.096 K | -1.210 M | -1.397 M | -1.676 M | -1.724 M | -1.607 M | -640.785 K | |
| 68.44% | 15.46% | 20.02% | 2.87% | -6.83% | -60.11% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -718.096 K | -1.210 M | -1.397 M | -1.676 M | -1.724 M | -1.607 M | -640.785 K | |
| -68.44% | -15.46% | -20.02% | -2.87% | 6.83% | 60.11% |
